✦ LIBER ✦

A prospective double-blind study of plasma exchange therapy for the acroparesthesia of Fabry's disease

✍ Scribed by H.G. Braine; R.E. Pyeritz; M.F. Folstein; H.B. Moser; M.D. Ullman

Book ID: 114437618
Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 312 KB
Volume: 21
Category: Article
ISSN: 0372-1248
DOI: 10.1046/j.1537-2995.1981.21682085755.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind, placebo controlled, mult

A double-blind, placebo controlled, multicentre study of tacrine for alzheimer's disease

✍ Philip C. Wood; Professor C. Mark Castleden 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

The present study was designed to determine whether oral tacrine (tetrahydroaminoacridine, THA) improves the symptoms of patients with mild to moderate Alzheimer's disease. The study was a multicentre, randomized doubleblind, placebo controlled, parallel group study with individual determination of

A First Prospective, Randomized, Double-

A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease

✍ Alessandro Palmieri; Ciro Imbimbo; Nicola Longo; Ferdinando Fusco; Paolo Verze; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 827 KB

A double-blind study of the effects of l

A double-blind study of the effects of levodopa in Parkinson's disease

✍ Nakano, K. K.; Tyler, H. R. 📂 Article 📅 1971 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 519 KB

D10S1423 identifies a susceptibility loc

D10S1423 identifies a susceptibility locus for Alzheimer’s disease in a prospective, longitudinal, double-blind study of asymptomatic individuals

✍ Zubenko, G S; Hughes III, H B; Stiffler, J S 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Liposomal Recombinant Human Superoxide D

Liposomal Recombinant Human Superoxide Dismutase for the Treatment of Peyronie's Disease: A Randomized Placebo-Controlled Double-Blind Prospective Clinical Study

✍ Claus R. Riedl; Peter Sternig; Günter Gallé; Florian Langmann; Brigitta Vcelar; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 226 KB

A randomised, double-blind, placebo-cont

A randomised, double-blind, placebo-controlled, crossover study to assess the efficacy and safety of three dosing schedules of agalsidase alfa enzyme replacement therapy for Fabry disease

✍ Hughes, D.A.; Deegan, P.B.; Milligan, A.; Wright, N.; Butler, L.H.; Jacobs, A.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 283 KB